
Overview
Aligo Alfa Spółka Z Ograniczoną Odpowiedzialnością is a venture capital firm that invests in early-stage startups focused on HealthTech and CleanTech innovations. The company supports projects such as dietary supplements for dermatological issues, digital therapeutics for cancer patients, and SaaS platforms for carbon footprint management. Additionally, it provides consulting services to help companies secure funding and accelerate growth.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | Covers prior losses | |
| Merger or transformation | Yes | |
| Related parties | 2 items | |
| Parent company | Aligo Alfa Sp. z o.o. |
Filing timeliness
Financial statements were filed on time, on average 31 days early. All were audited by a statutory auditor.
- 202510/07/2026
- 202414/07/2025
- 202304/07/2024
- 202202/06/2023
- 202101/07/2022
- 202023/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Wellbeing Polska joins Mavie Work – Aligo Venture Capital exit

LUX MED acquires Mental Path Group

Feyenally in the prestigious Techstars Healthcare Accelerator powered by Permanente Medicine

Prosoma raises €4.4 million in pre-Series A funding

Smarter Diagnostics with an ESA contract under the Ax-4 mission
Clients and partners
Websites
The site is available in: Polish and English.
- aligo.vcHome – AligoWordPress 3.7Google AnalyticsGoogle Tag ManagerYoast SEOWWPMLCloudflare
General partners
Manner of representation
The company is represented and its affairs are conducted by the general partner.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Unicorn Vr World sp. z o.o. | 553.75 USD | 20% | ||
Britescope sp. z o.o. | 9,940.57 USD | 14.3191% | ||
Biominds Healthcare sp. z o.o. | 1,485.68 USD | 23.2558% |
Bank accounts
Registered as a VAT taxpayer on 2018-09-18.
28 1750 1325 0000 0000 3998 7147
97 1600 1462 1085 5099 5000 0002
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Assay Management sp. z o.o. | $1,387,950.71 | assay.pl | ||
| TAR Heel Capital Pathfinder Vc S.K.A. | $932,915.29 | thcpathfinder.vc | ||
| FF Venture Capital S.K.A. | $714,031.48 | ffvc.pl | ||
| Satus Starter S.K.A. | $706,559.40 | satus.vc | ||
| Cofounderzone Corporate Angel Fund Asi S.K.A. | $411,614.83 | cofounder.zone | ||
| Pomerangels Asi S.A. | $405,216.77 | pomerangels.com | ||
| Idealab Venture Capital sp. z o.o. | $289,216.47 | idealab.pl | ||
| Knowledgehub Starter sp. z o.o. | $284,933.89 | kh.vc | ||
| Brave Seed Fund Kujawsko-Pomorski Fundusz Kapitałowy sp. z o.o. + limited partnership | $231,880.37 | brave.vc | ||
| Movens Venture Capital 1 S.K.A. | $201,217.25 | movenscapital.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-22 | Switch to PKD 2025 (1 PKD 2007 code → 1 PKD 2025 code) | |
| 2023-01-16 | Share capital increase (7,000,000.00 PLN → 8,050,000.00 PLN) | |
| 2022-01-05 | Share capital increase (5,000,000.00 PLN → 7,000,000.00 PLN) | |
| 2021-08-26 | Share capital increase (4,000,000.00 PLN → 5,000,000.00 PLN) | |
| 2020-12-30 | Share capital increase (3,000,000.00 PLN → 4,000,000.00 PLN) |
FAQ
Last updated: 2026-09-22